The BEST Study: The Efficacy of Brain Entrainment Sleep Technology in Military Healthcare Beneficiaries

Sponsor
Landstuhl Regional Medical Center (U.S. Fed)
Overall Status
Terminated
CT.gov ID
NCT03169309
Collaborator
(none)
7
1
1
8
0.9

Study Details

Study Description

Brief Summary

Brain Entrainment Technology (BET), also known as Binaural Beat Technology (BBT); is an auditory-neurophysiologic technique which uses auditory tones (often embedded in music, nature sounds or white noise) dichotically via stereo headphones to manipulate brainwave activity in turn affecting the listener's mental, physical and/or emotional state. Although this technology is widely marketed to the general public and can be found free in on the internet, only a hand full of scientific studies have shown its efficacy. This study is a follow-on study to the "Sound Mind Warrior (SMW) Study" (ClinicalTrials.gov [NCT02328690]) conducted 2012-2015 which assessed the efficacy of the technology (in the "theta" brainwave frequency) on the cardiovascular stress response in a group of service members with complaint of chronic stress. This study will now assess BET (in the "delta" brainwave frequency) on sleep quality in a population of military healthcare beneficiaries with complaint of poor sleep quality.

Condition or Disease Intervention/Treatment Phase
  • Device: Brain Entrainment Technology
N/A

Detailed Description

This study will follow a prospective, one group pre- and post-intervention design.

A sample of 162 military healthcare beneficiaries (within the Kaiserslautern Military Community footprint) with complaints of poor sleep quality will be instructed to wear sleep actigraphy monitors and complete daily sleep diaries upon waking for a total of four weeks. On weeks 3 and 4, participants will use BET at bedtime for a minimum of 30 minutes. Pre and post sleep quality measures will be compared along with pre- and post- c-reactive protein (CRP) measures and a post-study questionnaire to assess participants' perception about the technology.

Study Design

Study Type:
Interventional
Actual Enrollment :
7 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pre- and post- intervention trialPre- and post- intervention trial
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The BEST Study: The Efficacy of Brain Entrainment Sleep Technology in Military Healthcare Beneficiaries
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Sep 1, 2017
Actual Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pre and Post Intervention

One Study Arm - Quantitative and qualitative sleep quality measure will be captured at baseline (Phase I/Week 1-2), while using Brain Entrainment Technology (Phase II/Week3-4), and after using the technology.

Device: Brain Entrainment Technology
Brain Entrainment Technology (BET), also known as Binaural Beat Technology (BBT), is a sound technology where two slightly different tones are present to each ear and the brain produces a third tone. This third tone impacts the reticular activating system which alters the action potentials of the thalamus and cerebral cortex in turn changing the brain wave frequency to alter the state of consciousness of the listener.
Other Names:
  • Binaural Beat Technology
  • Outcome Measures

    Primary Outcome Measures

    1. "Quantitative" Sleep Quality (via Sleep Actigraphy Watch) [Daily over the course of 4 weeks]

      Sleep actigraphy monitor will measure wake/sleep. Using special software, that information is then articulated into graphical and tabulated report that shows the movement that occurred throughout the wake and sleep cycles as well as light exposure that may have affected sleep. The report gives the a) time the participants went to bed, b) time they woke up, c) number of hours they were in the bed, d) total number of hours asleep, e) number of minutes it took to fall asleep, f) percent efficiency of their sleep, g) number of minutes awaken after sleep onset, and h) total number of times they woke up after falling asleep.

    Secondary Outcome Measures

    1. Insomnia Severity Level (via Insomnia Severity Index Questionnaire) [Baseline]

      A 7-item questionnaire will be used as a screening tool to quantify the severity level of the participant's poor sleep quality. It is comprised of a 5-point Likert scale with a total score from 0-28 with 15 or greater indicating moderate to severe insomnia

    2. "Qualitative" Sleep Quality (via Sleep Foundation Sleep Diary Questionnaire) [Daily over the course of 4 weeks]

      A 14-item questionnaire will be used to capture sleep habits. Questions cover: napping, caffeine, alcohol, exercise, medication, meals, sleepiness, sleep hygiene, and quality. This instrument is not scored but merely used to assess patterns and if those patterns changed over the course of the study.

    3. Overall Impression of Sleep Quality (via Pittsburgh Sleep Quality Index Questionnaire) [Baseline and Week 4 (after using intervention)]

      A 24-item item questionnaire gives an accumulative score based on sub scores of sleep duration, sleep disturbance, sleep latency, number of days of dysfunction due to sleepiness, sleep efficiency, sleep quality, and medication usage. Minimum Score = 0 (better); Maximum Score = 21 (worse). Interpretation: TOTAL < 5 associated with good sleep quality and TOTAL > 5 associated with poor sleep,

    4. Inflammatory Biomarker (via C-Reactive Protein Lab) [Baseline and Week 4 (after using intervention)]

      A blood sample for c-reactive protein will measures the inflammatory process. After accounting for any external influences on CRP level, this measure will be correlated with the objective and subjective sleep data to assess if changes in sleep quality affected the inflammatory response.

    5. Extenuating Factor Affecting C-Reactive Protein Level (via C-Reactive Protein Questionnaire) [Baseline and Week 4 (after using intervention)]

      Since exposure to stress, infection, allergy, injury, or menstruation could affect CRP levels; this 6-item questionnaire will be used to note other possible co-variates that could have impacted CRP levels.

    6. Overall Impression of Brain Entrainment Technology (via Post Study Questionnaire) [Week 4 (after using intervention)]

      A 10-item questionnaire will be used at the completion of the study to instrument will capture any subjective comments from the participants as to assess the participant's perception about the technology as well as to assess ways that will help improve future studies using the same equipment and/or technology.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Score greater than or equal to 15 on the Insomnia Severity Index (ISI)

    • Affiliated with at least one of the 13 installations within the Kaiserslautern Military Community (KMC) area

    • Eligible to receive healthcare at Landstuhl Regional Medical Center (LRMC)

    • Are 18 years or older

    • Can read and speak English

    • Are able to commit to a 4 week study

    Exclusion Criteria:
    • Are taking any type of medication that causes drowsiness

    • Have been diagnosed with moderate to severe traumatic brain injury (TBI)

    • Have a history of epilepsy

    • Are taking any medication in the anti-seizure category

    • Have been diagnosed with, taking medication for, or are currently being evaluated for a psychological health issue as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) that will prohibit them from using intervention as perscribed.

    • Have ear trauma, difficulty hearing or wear a hearing aide

    • Have a chronic inflammatory health issue

    • Are pregnant or are trying to become pregnant in the next 4 weeks

    *Women of child bearing age will be asked to provide a urine sample for a pregnancy test

    • Are currently using BET

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Landstuhl Regional Medical Center Landstuhl Germany

    Sponsors and Collaborators

    • Landstuhl Regional Medical Center

    Investigators

    • Principal Investigator: MeLisa Gantt, PhD, Gantt Clinical Institute LLC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr MeLisa Gantt, (former) Chief, CNSCI, Landstuhl Regional Medical Center
    ClinicalTrials.gov Identifier:
    NCT03169309
    Other Study ID Numbers:
    • M-10544
    First Posted:
    May 30, 2017
    Last Update Posted:
    Nov 29, 2017
    Last Verified:
    Nov 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dr MeLisa Gantt, (former) Chief, CNSCI, Landstuhl Regional Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 29, 2017